Sanofi showcases innovationdriven, patientcentric vision at trade expo
2020-11-05 00:00
French biopharmaceutical company Sanofi is showcasing innovative therapies in fields such as immunology, rare diseases, oncology and neurology at the third China International Import Expo being held in Shanghai on Nov . The CIIE is an opportunity for Sanofi to demonstrate our innovationdriven and patientcentric vision under the theme of Better Health, Better Future Through Innovation, said Paul Hudson, CEO of Sanofi. He sees the expo as a platform to showcase Sanofis research and development efforts and possible breakthrough medicines that we could launch in the future for patients in China. China is at the core of Sanofis longterm strategy, Hudson said. We have been in the country since , working to improve the lives of millions of Chinese people and helping the government achieve its Healthy China  ambition. With the countrys health priorities in mind, Sanofi is accelerating its transformation to provide innovative medicines and vaccines, as well embracing the fastmoving digital revolution, according to Hudson. He said Sanofi is in China for China, with an endtoend footprint from RD to manufacturing to the supply of medicines and vaccines. Some of the recent collaborative projects between the company and its Chinese partners include the signing of a strategic cooperation agreement on vaccine innovation between Sanofi and the government of Shenzhen in South Chinas Guangdong province. The goal of the cooperation, according to Hudson, is to jointly promote international cooperation on vaccine research and development and improve access to vaccines. Another project, currently under construction, is a global RD operation center in the Southwest China city of Chengdu, which focuses on digital innovation and big data analysis. The COVID pandemic has brought Sanofis people closer and made them more committed, according to Hudson. What we do, as a company and an industry, has never been so important, he said. COVID has brought Sanofis teams around the world closer to their purpose and to each other. In response, Sanofi switched its interactions with healthcare professionals to digital communication technologies. Since the beginning of February, Sanofi China has conducted more than , hours of online training for its staff members and healthcare professionals, according to the company. Despite complexities created by the pandemic, Sanofi remains focused on its strategic priorities including China, said Hudson. Sanofi China will continue to accelerate the introduction of innovative medicines and vaccines for people across the country. We estimate that we will introduce more than  new medicines and vaccines by , said Hudson. He added, Digital innovation will also be embedded in all of our activities, from RD to medical communication, to partnerships with large companies and startups, working hand in hand to provide tailored healthcare solutions for Chinese patients. To achieve the longterm vision of Sanofi China, the company will continuously work to attract and develop top Chinese talent, Hudson noted.                 Sanofis main stand displays product information at the third China International Import Expo in Shanghai. CHINA DAILY             CHINA DAILY                                                                         !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html